J1267 – Injection, doripenem, 10 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ1267
- Long description
- Injection, doripenem, 10 mg
- Short description
- Doripenem injection
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- January 1, 2009
- Last change
- January 1, 2026 – No change
- Termination date
- December 31, 2025
Frequently asked questions
What is HCPCS code J1267?
J1267 is a HCPCS Level II code for injection, doripenem, 10 mg. It was discontinued on December 31, 2025.
Does Medicare cover J1267?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J1205 – Injection, chlorothiazide sodium, per 500 mg
- J1212 – Injection, dmso, dimethyl sulfoxide, 50%, 50 ml
- J1230 – Injection, methadone hcl, up to 10 mg
- J1240 – Injection, dimenhydrinate, up to 50 mg
- J1245 – Injection, dipyridamole, per 10 mg
- J1250 – Injection, dobutamine hydrochloride, per 250 mg
- J1260 – Injection, dolasetron mesylate, 10 mg
- J1265 – Injection, dopamine hcl, 40 mg
- J1270 – Injection, doxercalciferol, 1 mcg
- J1271 – Injection, doxycycline hyclate, 1 mg
- J1289 – Injection, narsoplimab-wuug, 1 mg
- J1290 – Injection, ecallantide, 1 mg
- J1299 – Injection, eculizumab, 2 mg
- J1300 – Injection, eculizumab, 10 mg
- J1301 – Injection, edaravone, 1 mg
- J1302 – Injection, sutimlimab-jome, 10 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.